» Articles » PMID: 28091596

Non-invasive Optical Estimate of Tissue Composition to Differentiate Malignant from Benign Breast Lesions: A Pilot Study

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jan 17
PMID 28091596
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Several techniques are being investigated as a complement to screening mammography, to reduce its false-positive rate, but results are still insufficient to draw conclusions. This initial study explores time domain diffuse optical imaging as an adjunct method to classify non-invasively malignant vs benign breast lesions. We estimated differences in tissue composition (oxy- and deoxyhemoglobin, lipid, water, collagen) and absorption properties between lesion and average healthy tissue in the same breast applying a perturbative approach to optical images collected at 7 red-near infrared wavelengths (635-1060 nm) from subjects bearing breast lesions. The Discrete AdaBoost procedure, a machine-learning algorithm, was then exploited to classify lesions based on optically derived information (either tissue composition or absorption) and risk factors obtained from patient's anamnesis (age, body mass index, familiarity, parity, use of oral contraceptives, and use of Tamoxifen). Collagen content, in particular, turned out to be the most important parameter for discrimination. Based on the initial results of this study the proposed method deserves further investigation.

Citing Articles

Widefield ultra-high-density optical breast tomography system supplementing x-ray mammography.

Mireles M, Xu E, Vanegas M, Muldoon A, Ragunathan R, Yan S Sci Rep. 2025; 15(1):8732.

PMID: 40082492 PMC: 11906649. DOI: 10.1038/s41598-025-92261-9.


Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential.

Mule N, Maffeis G, Cubeddu R, Santangelo C, Bianchini G, Panizza P Biomed Opt Express. 2024; 15(8):4842-4858.

PMID: 39346975 PMC: 11427201. DOI: 10.1364/BOE.527968.


In vivo optimization of the experimental conditions for the non-invasive optical assessment of breast density.

Serra N, Cubeddu R, Maffeis G, Damagatla V, Pifferi A, Taroni P Sci Rep. 2024; 14(1):19154.

PMID: 39160254 PMC: 11333589. DOI: 10.1038/s41598-024-70099-x.


Improving diffuse optical tomography imaging quality using APU-Net: an attention-based physical U-Net model.

Xue M, Li S, Zhu Q J Biomed Opt. 2024; 29(8):086001.

PMID: 39070721 PMC: 11272096. DOI: 10.1117/1.JBO.29.8.086001.


Experience using 675 nm laser on three cases of Fitzpatrick skin type IV-V with melasma.

Pamela R, Vitale M, Fusco I, Zingoni T, Yi K Skin Res Technol. 2024; 30(5):e13748.

PMID: 38766988 PMC: 11103554. DOI: 10.1111/srt.13748.


References
1.
Durduran T, Choe R, Baker W, Yodh A . Diffuse Optics for Tissue Monitoring and Tomography. Rep Prog Phys. 2015; 73(7). PMC: 4482362. DOI: 10.1088/0034-4885/73/7/076701. View

2.
Hubbard R, Kerlikowske K, Flowers C, Yankaskas B, Zhu W, Miglioretti D . Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011; 155(8):481-92. PMC: 3209800. DOI: 10.7326/0003-4819-155-8-201110180-00004. View

3.
Taroni P, Bassi A, Comelli D, Farina A, Cubeddu R, Pifferi A . Diffuse optical spectroscopy of breast tissue extended to 1100 nm. J Biomed Opt. 2009; 14(5):054030. DOI: 10.1117/1.3251051. View

4.
Walker R . The complexities of breast cancer desmoplasia. Breast Cancer Res. 2001; 3(3):143-5. PMC: 138677. DOI: 10.1186/bcr287. View

5.
Bassi A, Farina A, DAndrea C, Pifferi A, Valentini G, Cubeddu R . Portable, large-bandwidth time-resolved system for diffuse optical spectroscopy. Opt Express. 2009; 15(22):14482-7. DOI: 10.1364/oe.15.014482. View